← Eichor
Study identifier: NCT06588101 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU

Condition: Family Members · Recruitment · Clinical Study  ·  Sponsor: Lady Davis Institute

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).

This description comes directly from the study's public registry record.

Talk to the study team

Jillian Kifell, MSc  ·  5143408222  ·  jillian.kifell.ccomtl@ssss.gouv.qc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Jewish General HospitalMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06588101